Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Julia, Brinkmann"'
Autor:
Jan Simon Scharrenberg, Ayla Yagdiran, Julia Brinkmann, Maik Brune, Jan Siewe, Norma Jung, Esther Mahabir
Publikováno v:
Journal of Orthopaedic Surgery and Research, Vol 14, Iss 1, Pp 1-13 (2019)
Abstract Background There is still a challenge in discriminating between vertebral osteomyelitis and degenerative diseases of the spine. To this end, we determined the suitability of soluble urokinase-type plasminogen activator receptor (suPAR) and c
Externí odkaz:
https://doaj.org/article/1a75519498674fed91065ca6649a6163
This study is concerned with how founding stories are sustained across multiple generations of employees in family firms and how these stories influence organizational identification. Drawing on a social memory perspective and narrative memory work,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cddd71b48d32a2d26e8ebe55892aefec
https://doi.org/10.1177/08944865231159475
https://doi.org/10.1177/08944865231159475
Autor:
Margherita Bennetts, Michael Moran, Maik Häntschel, Julia Brinkmann, Kato Kambartel, Barbara Melosky, Federico Cappuzzo, Antonin Kayser, Dana J. Nickens
Publikováno v:
Molecular Diagnosis & Therapy
Background Identification of variable epidermal growth factor receptor (EGFR) gene mutations in non-small cell lung cancer (NSCLC) is important for the selection of appropriate targeted therapies. This meta-analysis was conducted to provide a worldwi
Autor:
Karsten Heusser, Jens Tank, Julia Brinkmann, Christoph Schroeder, Marcus May, Anika Großhennig, Daniela Wenzel, André Diedrich, Fred C. G. J. Sweep, Heidrun Mehling, Friedrich C. Luft, Jens Jordan
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 5, Iss 1 (2016)
BackgroundSympathetic and parasympathetic influences on heart rate (HR), which are governed by baroreflex mechanisms, are integrated at the cardiac sinus node through hyperpolarization‐activated cyclic nucleotide–gated channels (HCN4). We hypothe
Externí odkaz:
https://doaj.org/article/80a2a758af5d4c1f811930e94c27e295
Autor:
Gioia Mastromoro, Alma Kuechler, Francesca Clementina Radio, Yoann Vial, Elena Andreucci, Tuula Rinne, Erika Leenders, Kara Ranguin, Emanuela Scarano, Marine Legendre, Marion Gérard, Julia Brinkmann, Alessandro De Luca, Paola Daniele, Kerstin Kutsche, Francesca Pantaleoni, Ineke van der Burgt, Christina Lissewski, Maria Cristina Digilio, Hélène Cavé, Yline Capri, Valérie Chune, Francesca Romana Lepri, Martin Zenker, Marco Tartaglia, Laura Mazzanti
Publikováno v:
European Journal of Human Genetics, 29, 1, pp. 51-60
European Journal of Human Genetics
European Journal of Human Genetics, Nature Publishing Group, 2021, 29 (1), pp.51-60. ⟨10.1038/s41431-020-00708-6⟩
European Journal of Human Genetics, 29, 51-60
Eur J Hum Genet
European Journal of Human Genetics
European Journal of Human Genetics, Nature Publishing Group, 2021, 29 (1), pp.51-60. ⟨10.1038/s41431-020-00708-6⟩
European Journal of Human Genetics, 29, 51-60
Eur J Hum Genet
RASopathies are caused by variants in genes encoding components or modulators of the RAS/MAPK signaling pathway. Noonan syndrome is the most common entity among this group of disorders and is characterized by heart defects, short stature, variable de
Autor:
Marco Tartaglia, Dragana Josifova, Christina Lissewski, Martin Zenker, Luca Pannone, Viviana Claudia Canale, Massimiliano Anselmi, Simone Martinelli, Denny Schanze, Julia Brinkmann, Francesca Clementina Radio, Adonis S. Ioannides, Mina Ryten, Nils Rahner, Ina Schanze, Francesca Pantaleoni, Elisabetta Flex, Paolo Calligari, Lorenzo Stella, Gianfranco Bocchinfuso
Publikováno v:
Human Mutation. 41:1171-1182
Germline PTPN11 mutations cause Noonan syndrome (NS), the most common disorder among RASopathies. PTPN11 encodes SHP2, a protein tyrosine-phosphatase controlling signaling through the RAS-MAPK and PI3K-AKT pathways. Generally, NS-causing PTPN11 mutat
Autor:
Babette Julia Brinkmann
Publikováno v:
Menschenbilder und Digitalisierung ISBN: 9783658371630
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::325a51e098ffa370d5ab9e8617eb3350
https://doi.org/10.1007/978-3-658-37164-7_10
https://doi.org/10.1007/978-3-658-37164-7_10
Autor:
Marialetizia Motta, Maja Solman, Adeline A Bonnard, Alma Kuechler, Francesca Pantaleoni, Manuela Priolo, Balasubramanian Chandramouli, Simona Coppola, Simone Pizzi, Erika Zara, Marco Ferilli, Hülya Kayserili, Roberta Onesimo, Chiara Leoni, Julia Brinkmann, Yoann Vial, Susanne B Kamphausen, Cécile Thomas-Teinturier, Anne Guimier, Viviana Cordeddu, Laura Mazzanti, Giuseppe Zampino, Giovanni Chillemi, Martin Zenker, Hélène Cavé, Jeroen den Hertog, Marco Tartaglia
Publikováno v:
Human Molecular Genetics, 31(16), 2766-2778. Oxford University Press
Human Molecular Genetics
Human Molecular Genetics
We previously molecularly and clinically characterized Mazzanti syndrome, a RASopathy related to Noonan syndrome that is mostly caused by a single recurrent missense variant (c.4A?>?G, p.Ser2Gly) in SHOC2, which encodes a leucine-rich repeat-containi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4274a128c94c54387070cf691ea74309
https://hdl.handle.net/11573/1620615
https://hdl.handle.net/11573/1620615
Autor:
Otavio Clark, Tulio Sarmento, Anthony Eccleston, Julia Brinkmann, Renato Picoli, Vamsi Daliparthi, Jorine Voss, Sanjana Chandrasekar, Allison Thompson, Jane Chang
Publikováno v:
Journal of Clinical Oncology. 41:479-479
479 Background: Incidence and mortality for BC has changed very little over the past 20 years. Approximately 40% of patients with high-risk non-muscle invasive BC eventually recur/progress. It is important to understand the economic impact of disease
Autor:
Allison A. Petrilla, Alison R. Silverstein, Anthony Eccleston, Allison Thompson, Julia Brinkmann, Temitope Bello, Jane Chang, Joseph C Cappelleri, Sanjana Chandrasekar, Amy L Schroeder
Publikováno v:
Journal of Clinical Oncology. 41:473-473
473 Background: For patients with intermediate- to high-risk non-muscle invasive bladder cancer (NMIBC), standard of care includes transurethral resection (TURBT) followed by induction and maintenance intravesical immunotherapy with Bacillus Calmette